Home Newsfeeds Citigroup Downgrades Varonis Systems to Neutral, Announces $21 Price Target

Citigroup Downgrades Varonis Systems to Neutral, Announces $21 Price Target

Citigroup analyst Fatima Boolani downgrades Varonis Systems (NASDAQ:VRNS) from Buy to Neutral and announces $21 price target.

byBenzinga Newsdesk

November 1, 2022

1 minute read

Citigroup analyst Fatima Boolani downgrades Varonis Systems (NASDAQ:VRNS) from Buy to Neutral and announces $21 price target.

General
News

Believer Meats, ADM Collaborate To Develop Sustainable Meat Alternative

By Shivani Kumaresan

April 12, 12:40 PM

Food processing company Archer-Daniels-Midland Co (NYSE:ADM) has signed a non-exclusive memorandum of understanding (MOU) with Believer Meats to boost the development and commercialization of…

ADM

Co-Diagnostics Q2 EPS $(0.08) Misses $0.10 Estimate, Sales $5.00M Miss $20.50M Estimate

By Bill Haddad

August 11, 4:06 PM

Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $0.10 by 180 percent. This is a 124.24 percent decrease over earnings of $0.33 per share from the

CODX

Analyst Ratings

Beyond The Numbers: 4 Analysts Discuss Puma Biotechnology Stock

By Benzinga Insights

June 4, 11:01 AM

Ratings for Puma Biotechnology (NASDAQ:PBYI) were provided by 4 analysts in the past three months, showcasing a mix…

PBYI

Dodging the Penalty: AOM’s Star-Studded Line-Up Breathe Easy as EU Antitrust Inquiry Closes

By Akanksha Bakshi

May 23, 9:38 AM

The Alliance for Open Media (AOM) avoided a potential fine following the conclusion of an inquiry into its video licensing policies by EU antitrust investigators.

AAPL

Citigroup Downgrades Varonis Systems to Neutral, Announces $21 Price Target

Related Posts

Believer Meats, ADM Collaborate To Develop Sustainable Meat Alternative

Co-Diagnostics Q2 EPS $(0.08) Misses $0.10 Estimate, Sales $5.00M Miss $20.50M Estimate

Beyond The Numbers: 4 Analysts Discuss Puma Biotechnology Stock

Dodging the Penalty: AOM’s Star-Studded Line-Up Breathe Easy as EU Antitrust Inquiry Closes